Ybrain Signs Distribution Agreement for Digital Insomnia Therapeutic 'Somz'
MOU Signed with Ceragem Clinical, Aimed, and Aimnext
Strengthening Sleep Tech Business Following Launch of Insomnia Diagnostic Solution
On May 22, Ybrain, an electroceutical platform company, announced that it had signed a four-party business agreement to jointly distribute the digital insomnia treatment (DTx) Somz. Through this agreement, Ybrain plans to actively promote the distribution and sales of Somz to psychiatry and neurology clinics.
On the 22nd, to expand the distribution of the digital insomnia treatment Somz, Ybrain, Ceragem Clinical, Aimed, and Aimnext signed a four-party MOU. Ybrain
View original imageThe agreement involves a total of four companies: Ybrain, Ceragem Clinical, Aimed, and Aimnext. These companies plan to identify joint business opportunities and expand mutual cooperation in various digital healthcare fields, including insomnia treatment, wellness enhancement, fertility improvement, and senior and home care.
Through this agreement, Ybrain has entered into a strategic distribution partnership to expand the mental health market for Somz, Aimnext’s digital therapeutic device, and will also collaborate on joint research and development of sleep wellness solutions and programs.
Ceragem Clinical, based on its bed-type medical device platform, will work with Aimnext to promote a B2C (business-to-consumer) wellness product business aimed at improving sleep and fertility.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Recently, Ybrain launched the Mind Digital Sleep Diary, an insomnia diagnostic solution, and is further strengthening its business in the sleep tech sector through the distribution agreement for Somz. Kiwon Lee, CEO of Ybrain, stated, "Among experts, the importance of cognitive behavioral therapy in the actual treatment of patients diagnosed with insomnia is highly emphasized," adding, "We expect to support the real recovery of insomnia patients through infrastructure that can connect diagnosis and treatment within hospitals."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
